Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
03692.HK stock price ended at $37.24 on Perşembe, after dropping 1.90%
On the latest trading day Feb 12, 2026, the stock price of 03692.HK fell by 1.90%, dropping from $37.50 to $37.24. During the session, the stock saw a volatility of 4.18%, with prices oscillating between a daily low of $36.36 and a high of $37.88. On the latest trading day, the trading volume for 03692.HK rose by 1.7M shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 7.4M shares were traded, with a market value of approximately $221.4B.
03692.HKTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 0
Nötr Sinyaller 2
Satış Sinyalleri 5
Strong Sell
Sell
Neutral
Buy
Strong Buy
03692.HK, şu anda 0 alım sinyali ve 5 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Aşağı yönlü trend durumundadır ve bu dönemde toplam -1.9% fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Strong Sell görünüm işaret etmektedir.
03692.HK için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek 03692.HK için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.